logo
Winners, losers and grab-bags from House GOP's narrow passage of ‘Big, Beautiful Bill'

Winners, losers and grab-bags from House GOP's narrow passage of ‘Big, Beautiful Bill'

Fox News22-05-2025

With the narrow 215-214 passage of House Republicans' "Big, Beautiful Bill," (BBB) there were noted winners and losers, and some entities who felt mixed results from the midnight-oil-burning negotiations and vote.
The House Freedom Caucus (HFC) within the GOP conference appeared to be a key player in BBB talks, as Chairman Andy Harris of Maryland voted "present" while two other HFC members – Reps. Warren Davidson of Ohio and Thomas Massie of Kentucky voted "nay."
The HFC was initially very concerned about the bill's spending levels and how quickly – or not – some of the reduction measures would be implemented.
Ultimately, the HFC won out in terms of shifting Medicaid Work Requirements in the bill to take effect by 2027 rather than the originally-proposed 2029 deadline.
On the other GOP flank, moderates and lawmakers from blue states had expressed concern over the State and Local Tax Deduction (SALT) – which helps Democrat-run state residents lessen their tax burden.
Originally, SALT was capped at $10,000, but the budget bill raised it to $30,000 for individuals earning up to $400,000.
Rep. Michael Lawler, R-N.Y., and other blue-state Republicans clashed with President Donald Trump on the matter – with the president retorting that he knew Lawler's Rockland County district better than he did.
Lawler was seen as a winner in the budget bill's passage, as his work – along with Long Island Republicans like Rep. Nick LaLota, secured the deduction for their constituents.
Another blue state Republican, Rep. Andrew Garbarino of New York, was one of two nonvoting members – the other being Rep. David Schweikert, R-Ariz., according to the official roll.
Residents of such high-tax states as New York, New Jersey, Illinois, Maryland and California won out in that respect, ensuring that they would be able to continue to utilize SALT.
Outright winners in the bill were Trump and House Speaker Mike Johnson, R-La., -- who saw some version of their original effort come to pass.
Trump also saw his sweeping middle- and upper-class tax cuts preserved from expiration, which in turn rendered debt-and-deficit hawks proverbial losers.
Passage of the bill in the House comes as the national debt currently sits at $36,214,475,432,210.84, according to Fox Business' National Debt Tracker. The federal deficit will grow by about $2 trillion over 10 years, according to reports, while the tax cuts' preservation will reduce gross federal revenue.
But Medicaid and SNAP work requirements funding cuts are expected to lessen that blow.
Other winners included illegal immigration hawks, with the bill allocating billions for the Pentagon and for homeland security, including at the U.S.-Mexico border.
Energy interests also won out in the bill's passage.
The American Petroleum Institute applauded the House for taking another step to "restore American energy dominance."
"By preserving competitive tax policies, beginning to reverse the 'methane fee,' opening lease sales and advancing important progress on permitting, this historic legislation is a win for our nation's energy future," the group said in a statement.
Losers included Democratic leadership, as House Minority Leader Hakeem Jeffries, D-N.Y., saw his caucus vote as a bloc, but with just shy of the partisan force necessary to block the bill.
One particularly upset "loser" in the bill's passage was House Homeland Security Committee ranking member Bennie Thompson of Mississippi.
"You can't shovel s—t and call it sugar," Thompson fumed in a Thursday statement.
"This horrific bill is one of the most shameful grifts I have ever seen played on the American public," he added.
Abortion providers also lost out via the bill, as it reportedly bans Medicaid disbursements to Planned Parenthood for one year, which could lead to decreased revenue for such organizations.
Opponents of SALT, including members of the HFC also essentially lost out, given the fact the deduction remained intact and was somewhat bolstered.
The bill's slashing of green energy tax credits also renders that particular corporate sector – including wind, solar and EV concerns – another potential loser in the BBB.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Analysts assess the potential impact of Trump's surprise 50% steel tariffs
Analysts assess the potential impact of Trump's surprise 50% steel tariffs

Yahoo

time31 minutes ago

  • Yahoo

Analysts assess the potential impact of Trump's surprise 50% steel tariffs

-- U.S. President Donald Trump unexpectedly announced on Friday that steel and aluminum tariffs will double to 50%. The move, set to come into effect on June 4, was unveiled during a campaign rally in Pennsylvania. It was later confirmed on TruthSocial and comes amid broader debates around U.S. industrial policy and foreign investment. Analysts are now evaluating the implications of this surprise decision, with most agreeing that the immediate domestic effects may be less severe than the broader geopolitical risks. JPMorgan's Tatsuya Maruyama said the direct impact on major Japanese steelmakers such as Nippon Steel Corp (TYO:5401), JFE Holdings, Inc. (TYO:5411), and Kobe Steel, Ltd. (TYO:5406) is expected to be limited, given that 'the U.S. accounts for about 4% of Japan's steel exports.' Maruyama pointed out in a Monday note that Nippon Steel and JFE export only about 1% of their total shipments to the U.S., while Kobe Steel exports about 3%. Still, he warned that 'rising global protectionism' is a growing concern, noting that a wave of anti-dumping measures and safeguards in regions like South Korea, the EU, and India could further strain global trade dynamics. 'If such countermeasures gain momentum, Japanese steel products may also be targeted and the export environment may worsen,' Maruyama continued. Meanwhile, analysts at BMO Capital Markets believe the sudden tariff hike could jolt domestic markets. 'The doubling of import tariffs, if maintained, is likely to create a panic in the market and trigger a restocking cycle that in our view has the potential to push prices >$1,000/st in the near-term,' the analysts said. However, they believe the spike would be temporary given macro uncertainty and seasonal demand trends. The broker upgraded Nucor (NYSE:NUE) to Outperform but downgraded Algoma Central (TSX:ALC), which it called 'a relative tariff loser.' The aluminum market may be more exposed, according to BMO. The U.S. covers only about 20% of its own aluminum consumption domestically, making it more vulnerable to supply disruptions. 'If tariffs do double, this is expected to put material upside pressure on the Midwest premium (MWP),' BMO wrote, estimating it could reach '$0.75/lb-plus' in theory, although higher aluminum cost will likely weigh on demand and thus offset some upside pressure. That said, the brokerage sees Century Aluminum (NASDAQ:CENX) as well positioned to benefit from a rise in the Midwest premium, while Alcoa (NYSE:AA) could see a negative impact of $1–2 per share, or 4–7%, due to its reliance on Canadian production. Still, BMO expects Alcoa may redirect some of its Canadian output to the EU market. Related articles Analysts assess the potential impact of Trump's surprise 50% steel tariffs Street Calls of the Week VIDEO: How to analyze a stock like a pro with the CEO of HF Foods

1 Value Stock on Our Buy List and 2 to Approach with Caution
1 Value Stock on Our Buy List and 2 to Approach with Caution

Yahoo

time31 minutes ago

  • Yahoo

1 Value Stock on Our Buy List and 2 to Approach with Caution

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues. Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. Keeping that in mind, here is one value stock with strong fundamentals and two best left ignored. Forward P/E Ratio: 14.5x Synonymous with "dad shoe", Skechers (NYSE:SKX) is a footwear company renowned for its comfortable, stylish, and affordable shoes for all ages. Why Is SKX Risky? Constant currency revenue growth has disappointed over the past two years and shows demand was soft Estimated sales growth of 7.4% for the next 12 months implies demand will slow from its two-year trend Poor free cash flow margin of 4.4% for the last two years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends Skechers is trading at $62.04 per share, or 14.5x forward P/E. Dive into our free research report to see why there are better opportunities than SKX. Forward P/E Ratio: 9.9x Established in 1878, Mohawk Industries (NYSE:MHK) is a leading producer of floor-covering products for both residential and commercial applications. Why Are We Out on MHK? Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth ROIC of 3.5% reflects management's challenges in identifying attractive investment opportunities, and its decreasing returns suggest its historical profit centers are aging Diminishing returns on capital from an already low starting point show that neither management's prior nor current bets are going as planned At $100.61 per share, Mohawk Industries trades at 9.9x forward P/E. Check out our free in-depth research report to learn more about why MHK doesn't pass our bar. Forward P/E Ratio: 3.7x Pioneering treatments for a devastating childhood muscle-wasting disease that primarily affects boys, Sarepta Therapeutics (NASDAQ:SRPT) develops and commercializes RNA-targeted therapies and gene therapies for rare genetic disorders, primarily Duchenne muscular dystrophy. Why Are We Bullish on SRPT? Annual revenue growth of 51.3% over the last two years was superb and indicates its market share increased during this cycle Earnings per share grew by 38.8% annually over the last five years, massively outpacing its peers Cash burn has decreased over the last five years, showing the company is becoming a more self-sustaining business Sarepta Therapeutics's stock price of $37.50 implies a valuation ratio of 3.7x forward P/E. Is now the time to initiate a position? Find out in our full research report, it's free. Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store